Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    20580422 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly;   Drug: sitagliptin;   Drug: pioglitazone;   Drug: placebo tablet;   Drug: placebo once weekly
To Top

† Indicates status has not been verified in more than two years